NeoGenomics, Inc.

NASDAQ:NEO

Medical - Diagnostics & Research

Healthcare
$15.29 +6.03%

+$0.63 today

Market cap
$1.99B
Beta
1.81
P/E (TTM)
-2.9
EPS (TTM)
-$3.84
52W Low $4.72High $13.74

Volume 1.09M

Average 1.94M

NEO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

NeoGenomics, Inc.NASDAQ: NEO

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 130.83M shares rose 2.3% year over year, ahead of the +1.5% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 1.3% from the prior quarter. Over 3 fiscal years it compounded at +1.0% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +2.3% holds above the trailing-twelve-month pace of +1.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
130.83M+1.3% QoQ
Last fiscal yearDec 2025
128.1M+1.1% YoY
LTMJun 2026
129.14M+1.5% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.3%——
1 year+1.1%——
3-year CAGR+1.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
128.1M USD
Year-over-year change
+1.1%
4-year CAGR
+1.7%

Weighted Avg Shares (Diluted) vs competitors

How NEO compares with its peers on the latest reported figures

  • NEO's LTM Jun 2026 weighted avg shares (diluted) of 129.14M shares is the 2nd highest of the 10 companies compared; the peer median is 40.15M shares.
  • Its year-over-year change of +1.5% is the 9th highest of 10, against a peer median of +5.9%.
  • Over three fiscal years its annual growth of +1.0% compares with a peer median of +7.1%.
NEO Competitors Peer median
Weighted Avg Shares (Diluted) for NEO and competitors
Company Period LTM YoY 3-year CAGR
GHGuardant Health, Inc.LTM Sep 2026131.61M +5.9%+7.1%
NEONeoGenomics, Inc.LTM Jun 2026129.14M +1.5%+1.0%
PSNLPersonalis, Inc.LTM Mar 202693.42M +36.5%+25.0%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
VCYTVeracyte, Inc.LTM Jun 202681.15M +2.0%+4.0%
GRALGRAIL, Inc.LTM Jun 202640.15M +20.6%+5.8%
CSTLCastle Biosciences, Inc.LTM Mar 202629.46M +0.8%+3.6%
WGSGeneDx Holdings Corp.LTM Jun 202628.68M +2.4%+38.0%
XGNExagen Inc.LTM Mar 202622.36M +22.2%+8.1%
BDSXBiodesix, Inc.LTM Mar 20268.14M +14.9%+53.1%
FRNMFreenome, Inc. Common stock—— ——
Peer median (excluding NEO) 40.15M+5.9%+7.1%

Competitors are the stored peer set for NEO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue484.33M509.73M591.64M660.57M727.33M
Cost of Revenue297.27M321.83M347.04M370.47M444.79M
Gross Profit187.06M187.9M244.6M290.1M282.54M
Gross Margin38.6%36.9%41.3%43.9%38.8%
Research & Development21.87M30.33M27.31M31.16M37.08M
Selling, General & Admin283.94M277.91M279.96M310.49M365.34M
Operating Expenses305.81M345.52M352.34M382.21M348.62M
Depreciation & Amortization53.35M69.43M72.58M72.55M67.82M
EBITDA46.5M(82.33M)(17.61M)(1.51M)(38.69M)
EBITDA Margin9.6%-16.2%-3.0%-0.2%-5.3%
Operating Income(118.75M)(157.62M)(107.74M)(92.11M)(66.08M)
Operating Margin-24.5%-30.9%-18.2%-13.9%-9.1%
Interest Income3.14M6.08M16.9M18.43M9.07M
Interest Expense8.22M7.58M6.91M6.62M3.75M
Other Income / Expenses103.68M(1.72M)10.64M11.43M(44.19M)
Income Before Tax(15.08M)(159.34M)(97.1M)(80.68M)(110.27M)
Pre-Tax Margin-3.1%-31.3%-16.4%-12.2%-15.2%
Income Tax Expense(6.73M)(15.09M)(9.13M)(1.95M)(2.24M)
Net Income(8.35M)(144.25M)(87.97M)(78.73M)(108.03M)
Net Margin-1.7%-28.3%-14.9%-11.9%-14.9%
EPS (Basic)(0.07)(1.16)(0.70)(0.62)(0.84)
EPS (Diluted)(0.07)(1.16)(0.70)(0.62)(0.84)
Weighted Avg Shares119.96M124.22M125.5M126.66M128.1M
Weighted Avg Shares (Diluted)119.96M124.22M125.5M126.66M128.1M

NeoGenomics, Inc.

NASDAQ:NEO

Intrinsic Alpha fair value

Locked

Current Price

$15.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.